Dr. Vavalle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
CB 7050.
Chapel Hill, NC 27599Phone+1 919-966-4131Fax+1 919-966-1743
Summary
Education & Training
- Duke University HospitalFellowship, Interventional Cardiology, 2012 - 2013
- Duke University HospitalFellowship, Cardiovascular Disease, 2008 - 2012
- University of North Carolina HospitalsResidency, Internal Medicine, 2004 - 2008
- University of North Carolina at Chapel Hill School of MedicineClass of 2004
Certifications & Licensure
- NC State Medical License 2004 - 2025
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Alpha Omega Alpha University of North Carolina, 2016
Clinical Trials
- Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Start of enrollment: 2014 May 01
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR Start of enrollment: 2018 Jan 01
Publications & Presentations
PubMed
- 95 citationsStaring, a Novel E3 Ubiquitin-Protein Ligase That Targets Syntaxin 1 for Degradation*Lih-Shen Chin, John P. Vavalle, Lian Li
The Journal of Biological Chemistry. 2002-09-20 - 32 citationsThe REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndromeJohn P. Vavalle, Mauricio G. Cohen
Future Cardiology. 2012-05-29 - 5380 citationsApixaban versus Warfarin in Patients with Atrial FibrillationChristopher B. Granger, John H. Alexander, Renato D. Lopes, Elaine M. Hylek, Michael G. Hanna
The New England Journal of Medicine. 2011-09-14
Journal Articles
- Atrial FibrillationJohn Vavalle, MD, JACC: Cardiovascular Imaging
- Editorial Commentary: TAVR—Is There a Path to an All-Surgical-Risk Indication?John Vavalle, MD, ScienceDirect
Authored Content
- Netter's Cardiology 3rd Edition8/30/2018
- Cardiovascular Hemodynamics for the Clinician, 2nd Edition3/1/2017
Press Mentions
- Transcatheter Aortic Valve Replacement (TAVR) Associated with Shorter Hospital Stay, More Frequent Discharge to Home, Compared to Surgical Aortic Valve Replacement (SAVR)September 14th, 2018
- A Heart Team and Multi-Modality Imaging Approach to Percutaneous Closure of a Post-Myocardial Infarction Ventricular Septal DefectApril 12th, 2016
- TAVR Program Continues Growth, Fosters IntegrationJuly 23rd, 2016
- Join now to see all
Professional Memberships
- Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: